The CRISPR/Cas system inhibited the pro-oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells
2015 ◽
Vol 21
(5)
◽
pp. 608-618
◽
H-C Wang
◽
Y Yang
◽
S-Y Xu
◽
J Peng
◽
J-H Jiang
◽
...